A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...

Data shows Norway, which is similar in population size to NZ, increased its five-year survival rates for ovarian cancer from 34.1% to 46.1% in the almost two decades from 1995. In contrast, New ...

GSK has already made moves in this direction ... Chief executive Emma Walmsley said in a statement (PDF) that the revenue increase came from "strong growth in speciality medicines, including ...

Examining the implications of the recent US executive orders concerning diversity, equity, and inclusion pursuits—and the key ...

MANILA, Philippines — GSK plc (LSE/NYSE: GSK) has today released global survey data showing that over half (52%) of people aged 50-60 feel younger than their age—and nearly a fifth (19%) feel ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...

ICER has published the research protocol (PDF) for the evaluation of Breo Ellipta and Trelegy Ellipta – which made £1.1 billion (almost $1.5 billion) and £2.2 billion, respectively, for GSK ...

Pressurized metered-dose inhalers (pMDIs) for COPD and asthma contribute to climate change, and countries are moving away from their use.

India Cancer Immunotherapy Market Size Expands at Significant CAGR of 6.39% During 2024-2030, Reaching USD 102.11 Billion by 2030 Request To Download Free Sample of This Strategic Report @ ...

Africa Malaria Treatment Market Size Set Expands at Significant CAGR of 3.54% During 2024-2030 to Reach USD 124.54 Million by 2030 Request To Download Free Sample of This Strategic Report @ ...

The Indian QR coding programme introduced in 2023 to detect counterfeit medicines will instead now cause great harm.